Complement activation and adult respiratory distress syndrome during intermittent flow apheresis procedures
- 2 January 1986
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 26 (1) , 82-87
- https://doi.org/10.1046/j.1537-2995.1986.26186124040.x
Abstract
We observed complement (C) activation during intermittent flow apheresis procedures (Haemonetics model 30) in four subjects, two of whom developed adult respiratory distress syndrome (ARDS). Actual C3 conversion during apheresis was illustrated by the finding of significantly elevated C3d levels (p < 0.05) and of significantly increased alpha-1-antitrypsin/C3 ratios (p < 0.05) in postapheresis serums. Similarly, marked granulocyte aggregating activity was found in these serums, indicative of the generation of significant amounts of the C-derived anaphylatoxin, C5a or C5a desarginine. A mean decrease of 59.75 percent in neutrophil count during the four procedures suggested sequestration of aggregated granulocytes in the pulmonary vasculature. Moreover, granulocytes activated by apheresis serums induced significant 51Cr leak from cultured human endothelial cells in vitro (p < 0.001). We conclude that inflammatory C components produced during apheresis procedures may provoke granulocyte aggregation and embolization, leading to plugging of the pulmonary vasculature, and that apheresis-activated granulocytes may induce endothelial cytotoxicity, leading to the capillary leakage syndrome, characteristic of ARDS. Individual variability in C5a generation capacity of alterations in normal C5a clearing mechanisms may account for the low incidence of clinical C activation and true ARDS during apheresis. In these instances, high-dose steroids, which interfere with granulocyte-C interactions, may be beneficial.This publication has 23 references indexed in Scilit:
- Citrate Induced Hypocalcaemia during Cell SeparationBritish Journal of Haematology, 2008
- Corticosteroids block binding of chemotactic peptide to its receptor on granulocytes and cause disaggregation of granulocyte aggregates in vitro.Journal of Clinical Investigation, 1981
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981
- Metastatic Adenocarcinomas of Unknown Primary SiteNew England Journal of Medicine, 1980
- Venoconstrictor Activity of Some Precursor Fractions of Stable Plasma Protein SolutionVox Sanguinis, 1980
- Complement-Induced Granulocyte AggregationNew England Journal of Medicine, 1980
- Hypotension Associated with Prekallikrein Activator (Hageman-Factor Fragments) in Plasma Protein FractionNew England Journal of Medicine, 1978
- Complement and Leukocyte-Mediated Pulmonary Dysfunction in HemodialysisNew England Journal of Medicine, 1977
- Short‐Term and Long‐Term Effects of Plasmapheresis on Serum Proteins and ImmunoglobulinsTransfusion, 1975
- Le dosage du complémentTransfusion, 1967